Cargando…
The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
BACKGROUND: Gastrointestinal (GI) symptoms affect more than 80% of individuals with relapsing-remitting multiple sclerosis (RRMS). Ginger is widely known for its GI relieving properties. Therefore, we investigated the effect of ginger supplementation on common GI symptoms in RRMS patients. METHODS:...
Autores principales: | Foshati, Sahar, Poursadeghfard, Maryam, Heidari, Zahra, Amani, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605938/ https://www.ncbi.nlm.nih.gov/pubmed/37891539 http://dx.doi.org/10.1186/s12906-023-04227-x |
Ejemplares similares
-
The efficacy and safety of ginger supplementation in patients with multiple sclerosis: A rationale and study protocol for a double‐blind randomized controlled trial
por: Foshati, Sahar, et al.
Publicado: (2022) -
Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
por: Rezaee, Mehdi, et al.
Publicado: (2022) -
Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
por: Rahimlou, Mehran, et al.
Publicado: (2022) -
Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
por: Rahimlou, Mehran, et al.
Publicado: (2022) -
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)